This study proposes that DHX9 phosphorylation, which is impaired by cytotoxic stress, regulates chemotherapy-resistant CRC by promoting oncogenic circRNA expression, thereby providing mechanistic insights for the development of therapeutic strategies for recurrent and chemoresistant CRC. Here, DHX9 is linked to colorectal carcinoma.